Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus

Table 2

Change in HbA_1c (%) at various time points after VBLOC therapy initation in trial subjects with at least 5% BWL*.

Visit	𝑛	ΔHbA1c (%); mean ± SEM	Minimum	Maximum
1 Wk	4	−0.8±0.2	−1.2	−0.3
4 Wk	11	−1.0±0.2	−2.5	0.0
12 Wk	18	−1.2±0.2	−3.2	0.3
6 Mo	16	−1.1±0.3	−3.1	0.5
12 Mo	16	−1.4±0.2	−4.1	0.0

∗BWL: total body weight loss.